#USA #Waystar #Lehi, Utah #Public Offering #Healthcare Payments

Waystar Announces Public Offering Pricing

Waystar Holding Corp. has recently confirmed the pricing details of its public offering of common stock. The offering comprises 12,500,000 shares priced at $38.75 each, set to close around May 16, 2025. Notably, the shares are being made available through various investment funds, including those from EQT AB, Bain Capital, and the Canada Pension Plan Investment Board, collectively referred to as the Selling Stockholders.

In addition to the 12.5 million shares, the underwriters have been granted a 30-day option to acquire an extra 1,875,000 shares, enhancing the total potential offering. It’s important to stress that Waystar itself is not selling any shares and will not gain any financial proceeds from this transaction.

A robust underwriting team is managing the offering, including major players such as J.P. Morgan, Goldman Sachs Co. LLC, and Barclays, who are leading the initiative as joint book-running managers. Also supporting the venture are entities like William Blair, Evercore ISI, and BofA Securities, each assumed a role within the underwriting process.

This isn’t just an ordinary stock offering; it hinges on a formal registration statement filed with the Securities and Exchange Commission (SEC). This statement includes essential details such as a prospectus, which contains all necessary information for potential investors. However, potential investors should be aware that this announcement does not represent a solicitation for the purchase of shares and is bound by the legal prerequisites detailed in the Securities Act of 1933.

Forward-Looking Statements
This announcement also includes various forward-looking statements, as defined by the Private Securities Litigation Reform Act of 1995. These predictions hinge on management's expectations and are contingent upon numerous market factors and risks that may influence the outcome of this offering. Variations in circumstances that are tough to quantify may lead to different results than those projected. Waystar urges stakeholders to consider these factors carefully, as outlined in its registration filings with the SEC.

About Waystar

Waystar’s primary focus lies in revolutionizing healthcare payments through its advanced software solutions tailored specifically for this industry. As a vital player in the healthcare sector, the firm aims to streamline payment processes, enabling providers to better serve their patients. Presently, Waystar boasts approximately 30,000 clients and plays a pivotal role in managing over 6 billion healthcare payment transactions each year—a significant share that covers about 50% of patients in the U.S.

Waystar’s influence extends across prominent institutions, with 16 out of the 20 featured on the U.S. News Best Hospitals list utilizing its software. The organization is devoutly committed to redefining the healthcare payment landscape, so client organizations can concentrate on what truly matters: the care of their communities and patients.

For anyone interested in this public offering, preliminary prospectus copies can be requested via the contacts listed for the underwriting firms involved in the offering.

In conclusion, this capital venture signifies an essential step in Waystar's growth trajectory, solidifying its stance as a leader in healthcare payment technology as it prepares for the next phase of its corporate evolution.